[1] Loewenstein WR, Kanno Y.Intercellular communication and tissue growth I cancerous growth[J]. J Cell Biol, 1967, 33(2):225-234.
[2] Aasen T, Mesnil M, Naus CC, et al.Gap junctions and cancer: communicating for 50 years[J]. Nat Rev Cancer, 2016,16(12): 775-788.
[3] Revel JP, Karnovsky MJ.Hexagonal array of subunits in intercellular junctions of the mouse heart and liver[J]. J Cell Biol, 1967, 33(3): C7-C12.
[4] Graham SV, Jiang JX, Mesnil M.Connexins and pannexins: important players in tumorigenesis, metastasis and potential therapeutics[J]. Int J Mol Sci, 2018, 19(6):1645.
[5] Söhl G,Willecke K.An update on connexin genes and their nomenclature in mouse and man[J]. Cell Commun Adhes, 2003,10(4):173-180.
[6] Beyer EC, Berthoud VM.Gap junction gene and protein families: connexins, innexins, and pannexins[J]. Biochim. Biophys. Acta, 2018,1860(1): 58.
[7] Bai D.Structural analysis of key gap junction domains-Lessons from genome data and disease-linked mutants[J]. Semin Cell Dev Biol, 2016, 50(11):74-82.
[8] Goodenough DA, Paul DL.Gap junctions[J]. Cold Spring Harbor Perspect Biol, 2009, 1(1): 002576.
[9] Oyamada M, Oyamada Y, Takamatsu T.Regulation of connexin expression[J].Biochim Biophys Acta, 2006, 1719(1-2): 6-23.
[10] Aasen T, Johnstone S, Vidal-Brime L, et al.Connexins: synthesis, post-translational modifications, and trafficking in health and disease[J]. Int J Mol Sci, 2018,19(5):1296-1332.
[11] Howard W, Evans. Cell communication across gap junctions: a historical perspective and current developments[J]. Biochem Soc Trans, 2015, 43(3):450-459.
[12] Oyamada M, Takebe K, Oyamada Y.Regulation of connexin expression by transcription factors and epigenetic mechanisms[J]. Biochimica Et Biophysica Acta, 2013, 1828(1): 118-133.
[13] Mulkearns-Hubert EE, Reizes O, Lathia JD.Connexins in cancer: Jekyll or Hyde?[J]. Biomolecules, 2020, 10(12):1654.
[14] Zhou JZ, Jiang JX.Gap junction and hemichannel-independent actions of connexins on cell and tissue functions--an update[J]. FEBS Letters, 2014,588(8):1186-1192.
[15] Vinken M, Papeleu P, Snykers S, et al.Involvement of cell junctions in hepatocyte culture functionality[J]. Crit Rev Toxicol, 2006, 36(4):299-318.
[16] Paul DL.Molecular cloning of cDNA for rat liver gap junction protein[J]. J Cell Biol 1986;103(1):123-134.
[17] Kumar NM, Gilula NB.Cloning and characterization of human and rat liver cDNAs coding for a gap junction protein[J]. J Cell Biol 1986;10(3):767-776.
[18] Meyer DJ.Intercellular communication in normal and regenerating rat liver: a quantitative analysis[J]. J Cell Biol , 1981, 91(2 Pt 1): 505-523.
[19] Temme A, Ott T, Dombrowski F, et al.The extent of synchronous initiation and termination of DNA synthesis in regenerating mouse liver is dependent on connexin32 expressing gap junctions-ScienceDirect[J]. J Hepatol, 2000,32(4):627-635.
[20] Kojima T, Yamamoto T, Murata M, et al.Role of the p38 MAP-kinase signaling pathway for Cx32 and claudin-1 in the rat liver[J]. Cell Commun Adhes, 2003, 10(4-6): 437.
[21] Masahito O, Kumiko T, Aya E, et al.Connexin expression and gap-junctional intercellular communication in ES cells and iPS cells[J]. Front Pharmacol, 2013, 4(1):85.
[22] Vinken M, Kock JD, André G, et al.Modifications in connexin expression in liver development and cancer[J]. Cell Commun Adhes, 2012,19(3-4): 55-62.
[23] Baxter M, Withey S, Harrison S, et al.Phenotypic and functional analyses show stem cell-derived hepatocyte-like cells better mimic fetal rather than adult hepatocytes[J]. J Hepatol, 2015, 62(3):581-589.
[24] Qin J, Chang M, Wang S, et al.Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells[J]. Sci Rep, 2016, 6(1):373-388.
[25] Pei H, Zhai C, Li H, et al.Connexin 32 and connexin 43 are involved in lineage restriction of hepatic progenitor cells to hepatocytes[J]. Stem Cell Res Ther, 2017, 8(1):252.
[26] Wilson MR, Close TW, Trosko JE.Cell population dynamics (apoptosis, mitosis, and cell-cell communication) during disruption of homeostasis[J]. Exp Cell Res, 2000, 254(2): 257-268.
[27] Albright CD, Kuo J, Jeong S. cAMP enhances Cx43 gap junction formation and function and reverses choline defificiency apoptosis[J]. Exp Mol Pathol, 2001,71(1):34-39.
[28] Vinken M, Henkens T, Rop ED, et al.Biology and pathobiology of gap junctional channels in hepatocytes[J]. Hepatology, 2010, 47(3):1077-1088.
[29] Vinken M, Decrock E, Vuyst ED, et al.Connexin32 hemichannels contribute to the apoptotic-to-necrotic transition during Fas-mediated hepatocyte cell death[J]. Cell Mol Life Sci, 2010, 67(6):907-918.
[30] Vinken M.Gap junctions and non-neoplastic liver disease[J]. J Hepatol, 2012, 57(3): 655-662.
[31] Tiburcio TC,Willebrords J, Da Silva TC, et al.Connexin32 deficiency is associated with liver injury, inflammation and oxidative stress in experimental non‐alcoholic steatohepatitis[J]. Clin Exp Pharmacol Physiol, 2017, 44(2): 197-206.
[32] Sagawa H, Naiki-Ito A, Kato H, et al.Connexin 32 and luteolin play protective roles in non-alcoholic steatohepatitis development and its related hepatocarcinogenesis in rats[J]. Carcinogenesis, 2015,36(12):1539-1549.
[33] Igarashi I, Maejima T, Kai K, et al.Role of connexin 32 in acetaminophen toxicity in a knockout mice model[J]. Exp Toxicol Pathol, 2014, 66(2-3):103-110.
[34] Cogliati B, Crespo Yanguas S, Da Silva TC, et al.Connexin32 deficiency exacerbates carbon tetrachloride-induced hepatocellular injury and liver fibrosis in mice[J]. Toxicol Mech Methods, 2016, 26(5):362-370.
[35] Patel SJ, Milwid JM, King KR,et al.Gap junction inhibition prevents drug-induced liver toxicity and fulminant hepatic failure[J]. Nat Biotechnol, 2012, 30(2):179-183.
[36] Asamoto M, Hokaiwado N, Murasaki T, et al.Connexin 32 dominant-negative mutant transgenic rats are resistant to hepatic damage by chemicals[J]. Hepatology, 2010,40(1):205-210.
[37] Naiki-Ito A, Asamoto M, Naiki T, et al.Gap junction dysfunction reduces acetaminophen hepatotoxicity with impact on apoptotic signaling and connexin 43 protein induction in rat[J]. Toxicol Pathol, 2010, 38(2):280-286.
[38] Maes M, Mcgill MR, Da Silva T C, et al. Connexin32: a mediator of acetaminophen-induced liver injury?[J]. Toxicol Mech Methods, 2016,26(2): 88-96.
[39] Maes M, Crespo Yanguas S, et al.Connexin and pannexin signaling in gastrointestinal and liver disease[J].Transl Res, 2015; 166(4): 332-343.
[40] Evert M, Ott T, Temme A, et al.Morphology and morphometric investigation of hepatocellular preneoplastic lesions and neoplasms in connexin32-deficient mice[J]. Carcinogenesis, 2002, 23(5):697-703.
[41] Schwarz M, Wanke I, Wulbrand U, et al.Role of connexin32 and beta-catenin in tumor promotion in mouse liver[J]. Toxicol Pathol, 2003, 31(1):99-102.
[42] Sinyuk M, Mulkearns-Hubert EE, Reizes O, et al.Cancer Connectors: connexins, gap junctions, and communication[J]. Front Oncol, 2018, 8(8):646-654.
[43] Igarashi I, Makino T, Suzuki Y, et al.Background lesions during a 24-month observation period in connexin 32-deficient mice[J]. J Vet Med Sci, 2013,75(2):207-210.
[44] Evert M, Ott T, Temme A, et al.Morphology and morphometric investigation of hepatocellular preneoplastic lesions and neoplasms in connexin32deficient mice[J]. Carcinogenesis, 2002, 23(2):697-703.
[45] Yang Y, Yao JH, Du QY, et al.Connexin 32 downregulation is critical for chemoresistance in oxaliplatin-resistant HCC cells associated with EMT[J]. Cancer Manag Res, 2019, 11(1), 5133-5146.
[46] Naus CC, Laird DW.Implications and challenges of connexin connections to cancer[J]. Nat Rev Cancer, 2010,10(6):435-441.
[47] Li Q,Omori Y,Nishikawa Y,et al.Cytoplasmic accumulation of connexin32 protein enhances motility and metastatic ability of human hepatoma cells in vitro and in vivo[J]. Int J Cancer, 2007,121(3):536-546.
[48] Xiang Y, Wang Q, Guo Y, et al.Cx32 exerts anti-apoptotic and pro-tumor effects via the epidermal growth factor receptor pathway in hepatocellular carcinoma[J]. J Exp Clin Cancer Res, 2019, 38(1): 145.
